Document is current

Any future updates will be listed below

Sphingosine-1-phosphate receptor modulators versus interferon beta for the treatment of relapsing–remitting multiple sclerosis: findings from randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s10072-022-05988-y

Published Online: 2022-03-03

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark